Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Z Potter

Showing results (21-30 of 225) with videos related to

Pageof 23
Sort By:
Drugs|May 1, 1989
Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugsM V Rudorfer, W Z Potter
Medical Hypotheses|May 1, 1989
A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: a defect in tonic adrenaline mediated inhibition of locus coeruleus stimulationI N Mefford, W Z Potter
Clinical Neuropharmacology|January 1, 1990
Antidepressants, metabolites, and apparent drug resistanceW Z Potter, H K Manji
Psychopharmacology Series|January 1, 1993
Methods to facilitate early exploratory testing of novel psychopharmacologic agents in humansW Z Potter, R P Irwin
Psychopharmacology Bulletin|January 1, 1995
International Psychopharmacology Algorithm Project ReportK O Jobson, W Z Potter
The American Journal of Psychiatry|April 1, 1989
Combined fluoxetine and tricyclic antidepressantsM V Rudorfer, W Z Potter
Journal of Clinical Psychopharmacology|February 1, 1992
Valproate and mood disorders: perspectives. IntroductionW Z Potter, C L Bowden
The Psychiatric Clinics of North America|June 1, 1986
Neurochemical and neuroendocrine dysregulation in affective disordersR N Golden, W Z Potter
Archives of General Psychiatry|August 1, 1993
Are monoamine metabolites in cerebrospinal fluid worth measuring?W Z Potter, H K Manji
The Australian and New Zealand Journal of Psychiatry|January 6, 2000
Methodological considerations for the development of new treatments for bipolar disorderW Z Potter, M E Ozcan
Pageof 23

Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
Drugs|May 1, 1989
Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugsM V Rudorfer, W Z Potter
Medical Hypotheses|May 1, 1989
A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: a defect in tonic adrenaline mediated inhibition of locus coeruleus stimulationI N Mefford, W Z Potter
Clinical Neuropharmacology|January 1, 1990
Antidepressants, metabolites, and apparent drug resistanceW Z Potter, H K Manji
Psychopharmacology Series|January 1, 1993
Methods to facilitate early exploratory testing of novel psychopharmacologic agents in humansW Z Potter, R P Irwin
Psychopharmacology Bulletin|January 1, 1995
International Psychopharmacology Algorithm Project ReportK O Jobson, W Z Potter
The American Journal of Psychiatry|April 1, 1989
Combined fluoxetine and tricyclic antidepressantsM V Rudorfer, W Z Potter
Journal of Clinical Psychopharmacology|February 1, 1992
Valproate and mood disorders: perspectives. IntroductionW Z Potter, C L Bowden
The Psychiatric Clinics of North America|June 1, 1986
Neurochemical and neuroendocrine dysregulation in affective disordersR N Golden, W Z Potter
Archives of General Psychiatry|August 1, 1993
Are monoamine metabolites in cerebrospinal fluid worth measuring?W Z Potter, H K Manji
The Australian and New Zealand Journal of Psychiatry|January 6, 2000
Methodological considerations for the development of new treatments for bipolar disorderW Z Potter, M E Ozcan
Pageof 23